Inactive Instrument
LungLife AI, Inc. Stock
Stocks
LLAI
USU5500L1045
Biotechnology & Medical Research
| 1 day | -2.35% |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul Pagano
CEO | Chief Executive Officer | 42 | - |
David Anderson
DFI | Director of Finance/CFO | 63 | - |
Michael Donovan
CTO | Chief Tech/Sci/R&D Officer | 72 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sara Barrington
BRD | Director/Board Member | 59 | 08/07/2021 |
David Anderson
BRD | Director/Board Member | 63 | 08/07/2021 |
Paul Pagano
BRD | Director/Board Member | 42 | 15/05/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/4/24 A | Free | Chief Financial Officer | 386,703 | 1.5173% | ||
| 10/4/24 A | Free | Chief Executive Officer | 769,707 | 3.0201% | ||
| 8/14/23 A | Buy | Chief Executive Officer | 12,123 | 0.0476% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.35% | +18.57% | - | - | 1.7M | |
| -1.77% | -2.88% | +120.24% | +104.15% | 4.44B | |
| +1.21% | +3.11% | +109.67% | +188.24% | 3.61B | |
| -1.80% | -2.39% | +56.55% | -30.30% | 2.19B | |
| +3.12% | +3.21% | -28.32% | -36.33% | 2.13B | |
| -2.10% | -5.24% | +184.28% | +239.50% | 1.88B | |
| -1.04% | -4.29% | +148.70% | -41.47% | 987M | |
| +2.92% | +6.02% | -6.47% | +23.96% | 875M | |
| +2.41% | -2.94% | -41.15% | -15.48% | 491M | |
| +2.96% | +12.06% | +2.70% | - | 468M | |
| Average | +0.36% | +1.01% | +60.69% | +54.03% | 1.9B | |
| Weighted average by Cap. | -0.04% | -0.33% | +85.60% | +85.54% |
Employees
8
